Blog

Stroke, Major Bleeding Risk Low with Dabigatran Etexilate
Monthly Prescribing Reference (registration)
WASHINGTON, DC—At the ACC.17 Scientific Session, study authors presented data which showed that the rates of stroke and major bleeding were low with dabigatran etexilate 110mg or 150mg twice daily doses, emphasizing the long-term safety and …